Pharma & Healthcare in Argentina: Turning a Corner?
Has Argentina, for years one of the economic basket cases of Latin America, finally turned a corner? And is its pharma industry set for a bounce back? Firebrand TV…
The Andreani Logistics Group is an Argentinian company started in 1945 in the province of Santa Fe and refounded in 1970 in Buenos Aires, where he managed to develop the largest physical distribution network nationwide, becoming a pioneer and leader in logistics services with high added value.
It comprises four business units in Argentina, Logistics, Pharma, Real Estate Development, and Logistics in Brazil. It also has the Andreani Foundation, through which jointly develops educational and cultural activities in Argentina.
Total installed area: 748,000 m2 total; 283,000 m2 covered
Employees: 6,000 (4,000 in dependent).
Fleet: 1,263 vehicles (Arg and Brazil.) Of different bearing
Turnover projected for 2014: $ 2,250 million pesos
Projected investment in 2014: $ 100 million pesos
Distribution billing business branches: Automotive / Auto Parts: 3%; Cosmetics: 4.5%; Pharmaceutical and Medical Technology: 37%; Machinery and Tools: 7%; Official Bodies: 3%; Financial Services: 11%; Technology and Electros: 5.5%; Telecommunications: 9%; Direct Sales: 3%; Other: 17%.
Commercial portfolio: over 1,000 customers, including highlights Abbott Laboratories, Arcor, Banco Hipotecario, Banco Santander, Bayer, Claro, Farmanet, Godrej Group, Hewlett Packard, Johnson & Johnson Medical, Massalin Special (Philip Morris), Merial, Natura Cosmetics, Nextel, British American Tobacco, Telecom, Telefonica, YPF, among others.
Other strategic investments 2014: Stage construction Norlog scheduled for July 2014 $ 100 million covering 37 hectares (investment Projection complete u $ s 400 million work). Norlog is the main project of Real Estate Development Business Unit, a logistics platform, located on 100 hectares in the northern suburbs of Buenos Aires, for the movement and storage of goods and establishment of light industries.
CONTACT INFO
Grupo Logístico Andreani
Santo Domingo 3220, Ciudad de Buenos Aires
Argentina
+54-0810-122-2345
Pharmaceutical Logistics
Tel .: (011) 5289-6412
Logistics in Brazil
Tel .: (011) 5289 6759 (Buenos Aires, Argentina)
Tel .: (+55 11) 3515-8200 (São Paulo, Brazil) / E-Mail: contato@andreani.com
Has Argentina, for years one of the economic basket cases of Latin America, finally turned a corner? And is its pharma industry set for a bounce back? Firebrand TV…
Gustavo Pelizzari leads Elea, Argentina’s largest pharmaceutical company by sales volume, employing 1,350 people. Under his leadership, Elea has achieved the unique distinction of simultaneously leading both the retail pharmaceutical…
Gala Díaz Langou, a senior analyst and executive director at Argentina’s premier think tank CIPPEC, assesses the country’s recent transformative journey under President Milei. Drawing on 25 years of institutional…
Keila Barral, founder of Cromodata, brings together a personal journey of resilience and a career in technology to address one of Latin America’s biggest healthcare challenges: fragmented patient data. After…
Argentina’s pharmaceutical industry combines a robust domestic manufacturing base with growing international reach and regulatory credibility. In this interview, Mauricio Claverí, Chief Economist at CILFA, explores how local companies are…
Juan Jose Marconi, Executive Director of Cooperala, offers a unique perspective shaped by decades of leadership across Argentina’s pharmaceutical and healthcare sectors. With a strong academic background in applied mathematics,…
MSD’s Leonardo Semprun, writing in the June 2025 edition of DIA’s Global Forum magazine, reflects on some of the key lessons from the Latin America Town Hall at DIA Europe…
A roundup of some of the biggest stories coming out of Latin American pharma and healthcare, including Mexico’s move to speed up the drug review process; Sanfer’s acquisition of Columbia’s…
A roundup of top stories from Latin American pharma and healthcare, including the beginning of the Mexican government’s consolidated procurement of medicines; Libbs’ new biologics plant; Novo Nordisk’s USD 142.4…
An overview of some of the biggest news from Latin American pharma, including Onconic Therapeutics’ licensing deal with Laboratorios Sanfer for 19 LatAm countries; Lupin’s orphan drug partnership with Argentina’s…
A roundup of some of the latest stories coming out of Latin American pharma and healthcare, including Merck’s new distribution centre in Brazil; the region’s record dengue surge; Roemmers Laboratory’s…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Mariana Abdala of Crystal Research outlines the vast room for improvement in Latin America’s clinical trial output, the region’s…
See our Cookie Privacy Policy Here
